For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Adicet Bio Inc (NASDAQ: ACET) closed the day trading at $0.68 up 6.67% from the previous closing price of $0.64. In other words, the price has increased by $6.67 from its previous closing price. On the day, 1.22 million shares were traded. ACET stock price reached its highest trading level at $0.699 during the session, while it also had its lowest trading level at $0.6355.
Ratios:
For a better understanding of ACET, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.48 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.09.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 56837368 and an Enterprise Value of -52767644.
Stock Price History:
The Beta on a monthly basis for ACET is 1.67, which has changed by -0.5416107 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, ACET has reached a high of $1.63, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -2.06%, while the 200-Day Moving Average is calculated to be -16.33%.
Shares Statistics:
Over the past 3-months, ACET traded about 485.13K shares per day on average, while over the past 10 days, ACET traded about 1081260 shares per day. A total of 83.25M shares are outstanding, with a floating share count of 65.78M. Insiders hold about 20.99% of the company’s shares, while institutions hold 43.09% stake in the company. Shares short for ACET as of 1753920000 were 4031291 with a Short Ratio of 8.31, compared to 1751241600 on 3316444. Therefore, it implies a Short% of Shares Outstanding of 4031291 and a Short% of Float of 6.52.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Adicet Bio Inc (ACET) reflects the combined expertise of 6.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.24 and low estimates of -$0.31.
Analysts are recommending an EPS of between -$1.1 and -$1.3 for the fiscal current year, implying an average EPS of -$1.23. EPS for the following year is -$1.06, with 6.0 analysts recommending between -$0.96 and -$1.21.
